Steering Committee

Michael J. Thorpy, MD

Dr. Thorpy is a professor of clinical neurology at Albert Einstein College of Medicine and director of the Sleep-Wake Disorders Center in the Department of Neurology at Montefiore Medical Center, both inNew York. In addition to treating patients with sleep disorders, he conducts research in narcolepsy, insomnia and sleep apnea. He is President of the New York State Society of Sleep Medicine. He has published more than 100 peer-reviewed articles and chapters. Dr. Thorpy received the Nathaniel Kleitman Award from the American Academy of Sleep Medicine, one of the field's highest honors, and the Lifetime Achievement Award from the National Sleep Foundation.

Thomas E. Scammell, MD

Dr. Scammell is a Professor in Neurology at Harvard Medical School, Beth Israel Deaconess Medical Center, and Boston Children's Hospital. He is a member of the International Classification of Sleep Disorders Task Force and a former member of the Sleep Research Society Board of Directors and the APSS Program Committee. The author of over 100 journal articles, Dr. Scammell has lectured both nationally and internationally on narcolepsy and the neurobiology of sleep and wakefulness. His current research interests include identifying how loss of orexin signaling results in sleepiness and cataplexy, interactions of sleep and pain, and the cause of sleepiness after traumatic brain injury.

David Pasta, Vice President, Medical Affairs Statistical Analysis

David Pasta is Vice President, Medical Affairs Statistical Analysis, at ICON plc. David has over 35 years of experience as a statistician and has authored over 110 peer-reviewed publications and an array of other publications and presentations. His areas of focus include the analysis of multiwave longitudinal data, statistical adjustment of group baseline differences, and the use of statistical graphics. Much of his work has been in the application of statistics to health-related information reported by patients, including health-related quality of life, patient satisfaction, and the psychosocial aspects of human reproductive behavior. He also has extensive experience working on clinical outcomes, especially in cystic fibrosis, and the economics of healthcare and in other fields such as educational program evaluations, criminal recidivism, and sampling of hard-to-sample populations. David earned his undergraduate degree in statistics from Princeton University and graduate degree from Stanford University. Previously he was president of his own statistical consulting, data management, and scientific software development company and founding director of the data management and analysis unit at Technology Assessment Group in San Francisco, later Lewin-TAG, a subsidiary of Quintiles Transnational.

Kathleen F. Villa, MS

Kathleen is the head of health economics and outcomes research (HEOR) at Jazz Pharmaceuticals and has been in the field of health outcomes research for the past 18 years. Kathleen has authored and collaborated on dozens of peer-reviewed publications and scientific presentations on the economic and humanistic burden of health conditions such as narcolepsy, schizophrenia and stroke. She has also studied the economic impact and cost-effectiveness of many new pharmaceutical interventions. Kathleen has extensive experience in observational research, economic modeling, claims database analysis and patient-reported outcomes.